UNICA IRIS Institutional Research Information System

PERSANO, MARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 19.784
NA - Nord America 1.481
AS - Asia 1.411
SA - Sud America 174
AF - Africa 34
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 22.889
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 19.250
US - Stati Uniti d'America 1.425
SG - Singapore 557
CN - Cina 386
VN - Vietnam 169
SE - Svezia 138
BR - Brasile 128
DE - Germania 84
FR - Francia 72
IN - India 60
HK - Hong Kong 58
FI - Finlandia 56
GB - Regno Unito 50
NL - Olanda 33
CA - Canada 31
BD - Bangladesh 23
KR - Corea 22
AT - Austria 19
PL - Polonia 19
JP - Giappone 17
AR - Argentina 16
IQ - Iraq 15
MX - Messico 14
TR - Turchia 12
ES - Italia 11
PK - Pakistan 11
PH - Filippine 10
AE - Emirati Arabi Uniti 9
IE - Irlanda 9
MA - Marocco 9
VE - Venezuela 8
ZA - Sudafrica 8
EC - Ecuador 7
ID - Indonesia 7
RU - Federazione Russa 7
SA - Arabia Saudita 7
BE - Belgio 6
IL - Israele 6
IR - Iran 6
TH - Thailandia 6
UZ - Uzbekistan 6
AU - Australia 4
CH - Svizzera 4
CO - Colombia 4
GR - Grecia 4
JO - Giordania 4
KG - Kirghizistan 4
BG - Bulgaria 3
DZ - Algeria 3
PE - Perù 3
PT - Portogallo 3
PY - Paraguay 3
TT - Trinidad e Tobago 3
AL - Albania 2
AM - Armenia 2
BH - Bahrain 2
BO - Bolivia 2
CL - Cile 2
DM - Dominica 2
DO - Repubblica Dominicana 2
HR - Croazia 2
KE - Kenya 2
LT - Lituania 2
MY - Malesia 2
NG - Nigeria 2
OM - Oman 2
RO - Romania 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BJ - Benin 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
EG - Egitto 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LY - Libia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NO - Norvegia 1
PA - Panama 1
RS - Serbia 1
SV - El Salvador 1
TN - Tunisia 1
UA - Ucraina 1
UG - Uganda 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 22.889
Salva come PNG Salva come JPEG
Città #
Cagliari 18.124
Uta 989
Singapore 361
Ashburn 223
Dallas 127
San Jose 126
Boardman 98
Nyköping 77
Beijing 73
Los Angeles 67
Chandler 55
Hong Kong 55
Ho Chi Minh City 52
Fairfield 51
Hanoi 46
Hefei 44
Helsinki 42
The Dalles 37
New York 34
Chicago 31
Santa Clara 31
Rome 27
Seattle 26
Houston 25
Seoul 22
Lauterbourg 21
Munich 21
Shanghai 21
Amsterdam 19
Council Bluffs 19
Pune 19
São Paulo 19
Woodbridge 18
Boston 17
Buffalo 17
Cambridge 17
Guangzhou 16
San Diego 16
Wilmington 15
Nuremberg 14
Frankfurt am Main 13
Orem 13
Redondo Beach 13
Salt Lake City 13
Warsaw 13
Lappeenranta 11
Montreal 11
Shenzhen 11
Stockholm 11
Chennai 10
London 10
Toronto 10
Düsseldorf 9
Tianjin 9
Haiphong 8
Roubaix 8
Vienna 8
Dubai 7
Dublin 7
Rio de Janeiro 7
Zhengzhou 7
Da Nang 6
Milan 6
Paris 6
Tashkent 6
Tokyo 6
Baghdad 5
Belo Horizonte 5
Brooklyn 5
Florence 5
Manila 5
Menlo Park 5
Naples 5
Wuhan 5
Amman 4
Bexley 4
Bishkek 4
Brussels 4
Dong Ket 4
Johannesburg 4
La Maddalena 4
Maebashi 4
Manchester 4
Mexico City 4
Nanjing 4
Poplar 4
Porto Alegre 4
Quito 4
Romainville 4
Zurich 4
Atlanta 3
Biên Hòa 3
Brasília 3
Campinas 3
Casablanca 3
Charlotte 3
Clifton 3
Elk Grove Village 3
Hải Dương 3
Istanbul 3
Totale 21.485
Salva come PNG Salva come JPEG
Nome #
Molecular-biology-driven treatment for metastatic colorectal cancer 2.771
New therapeutic targets in pancreatic cancer 1.634
Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients? 1.539
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment 1.357
Molecular-driven treatment for biliary tract cancer: the promising turning point 1.222
CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors 1.074
Neoadjuvant chemo-radiotherapy response in patients affected by mismatch repair deficient (dMMR) locally advanced rectal cancer 987
Retrospective Comparative Analysis of KRAS G12C vs. Other KRAS Mutations in mCRC Patients Treated With First-Line Chemotherapy Doublet + Bevacizumab 960
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients 959
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast? 934
The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment 868
New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression 786
Corrigendum: Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients 775
Uncovering key targets of success for immunotherapy in pancreatic cancer 720
Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus 676
BRCA-mutant pancreatic ductal adenocarcinoma 618
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging 597
Immune Checkpoint Inhibitors in the Treatment of HCC 590
Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment 586
Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis 379
Validation of the easy-to-use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinib 367
Different Genomic Clusters Impact on Responses in Advanced Biliary Tract Cancer Treated with Cisplatin Plus Gemcitabine Plus Durvalumab 301
α-FAtE: A new predictive score of response to atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma 299
Updated survival outcomes with ivosidenib in patients with previously treated IDH1-mutated intrahepatic-cholangiocarcinoma: an Italian real-world experience 295
Identification of Atezolizumab Plus Bevacizumab Prognostic Index via Recursive Partitioning Analysis in HCC: The ABE Index 278
Mismatch repair proteins (MMR) expression as predictive factor in locally advanced rectal cancer 210
Adverse Events as Potential Predictive Factors of Activity in Patients with Advanced HCC Treated with Atezolizumab Plus Bevacizumab 209
Safety and Efficacy of Lenvatinib in Very Old Patients with Unresectable Hepatocellular Carcinoma 204
Thyroid dysfunction and immune checkpoint inhibitors: Effect on survival in elderly patients 199
Disease Etiology Impact on Outcomes of Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab: A Real-World, Multicenter Study 198
Overall survival and progression-free survival in metastatic colorectal cancer patients with concomitant RAS and BRAF mutations: a single center experience 170
Lymphocyte to monocyte ratio in metastatic pancreatic ductal adenocarcinoma as a prognostic factor and its potential role in identifying a subset of patients with a favorable response to therapy 100
Atezolizumab plus bevacizumab versus Lenvatinib for patients with Barcelona clinic liver cancer stage B (BCLC-B) hepatocellular carcinoma (HCC): A real-world population 89
A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC‐D Index 59
Totale 23.010
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.565
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.565
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021366 0 0 0 0 0 0 0 0 0 161 109 96
2021/20221.411 84 65 4 47 57 107 68 164 112 154 244 305
2022/20233.457 301 460 353 253 266 336 167 257 238 379 291 156
2023/20243.389 144 130 116 191 285 576 596 252 191 206 335 367
2024/20259.142 2.411 2.892 824 954 437 609 481 53 103 161 84 133
2025/20263.062 265 192 251 282 243 240 791 313 239 246 0 0
Totale 23.010